Treatment
Shockwave therapy
Low-intensity shockwave therapy is sometimes offered for Peyronie's disease, but the evidence base remains thin.
Shockwave devices deliver acoustic energy to tissue. The premise in Peyronie's is that this energy might affect plaque or improve local circulation. The data so far is mixed and harder to interpret than the trials behind traction or surgery.
Some clinicians offer shockwave for pain in the active phase. Some offer it as a structural treatment. The evidence is stronger for the first use than the second.
What to know about shockwave therapy
More evidence for pain than for shape
Where shockwave has shown reasonable signal is on pain in active-phase Peyronie's. Curvature reduction is less reliably supported.
Variability between devices and protocols
Shockwave is not one treatment. Devices, energy levels, and protocols vary widely, and the evidence does not transfer between them.
Cost and access vary
It is often offered out-of-pocket and varies by region. Verify what the clinic uses, what the protocol is, and what the published outcomes are.
Short-term, low-risk profile
For most men, the procedure itself is well-tolerated. The question is usually whether the time and cost are justified.
Not a replacement for stronger-evidence options
When curvature and length are the goals, traction therapy carries more device-specific evidence. Shockwave is not a substitute.
Ask what shockwave is expected to do in your situation, pain, structure, or both, and what the published evidence is.
Stay informed
Get practical Peyronie's updates
Receive new guides, treatment explainers, and evidence-based updates by email. Unsubscribe at any time.